Myla Lai - Sep 16, 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Myla Lai-Goldman, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Sep 16, 2021
Transactions value $
$0
Form type
4
Date filed
9/20/2021, 08:51 PM
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Stock Option (Right to Buy Award $0 +39K $0.00 39K Sep 16, 2021 Common Stock 39K $18.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuous service through the vesting date, the options shall vest in three (3) equal installments beginning on September 16, 2022 and annually thereafter until fully vested.